Anticancer potential of lichens’ secondary metabolites

131Citations
Citations of this article
160Readers
Mendeley users who have this article in their library.

Abstract

Lichens produce different classes of phenolic compounds, including anthraquinones, xanthones, dibenzofuranes, depsides and depsidones. Many of them have revealed effective biological activities such as antioxidant, antiviral, antibiotics, antifungal, and anticancer. Although no clinical study has been conducted yet, there are number of in vitro and in vivo studies demonstrating anticancer effects of lichen metabolites. The main goal of our work was to review most recent published papers dealing with anticancer activities of secondary metabolites of lichens and point out to their perspective clinical use in cancer management.

Cite

CITATION STYLE

APA

Solárová, Z., Liskova, A., Samec, M., Kubatka, P., Büsselberg, D., & Solár, P. (2020, January 1). Anticancer potential of lichens’ secondary metabolites. Biomolecules. MDPI AG. https://doi.org/10.3390/biom10010087

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free